Eye tests to measure visual speed in multiple sclerosis
Part of Brain & nervous system, Eyes & vision, Immune system & allergy clinical trials.
This study tests how fast and how accurately your eyes process visual information and how eye movements look in people with multiple sclerosis. It may help researchers understand vision-related effects of MS using objective eye measurements.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of multiple sclerosis (MS)
- Your distance vision with glasses or soft contacts is at least 0.7
- Your near (close-up) vision with glasses or soft contacts is at least 20/30
- You do not have recent or repeated episodes of optic neuritis within the past 6 months
- No other eye diseases or cataracts that significantly block vision
- Your glasses/contact prescription is not too strong (refractive error within ±6 diopters)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special eye scan (OCT-A) and a vision test (perimetry) to see how MS affects the eyes over time. It may help doctors better understand and monitor MS-related eye damage.
This study checks how well new eye-tracking software can measure eye movements in people with multiple sclerosis. It may help researchers track changes in how the nervous system works using a simple camera-based eye test.
This trial uses eye movement tracking and simple cognitive tests to study how thinking and memory may be affected in people with multiple sclerosis (MS). The goal is to better understand how MS can impact everyday mental skills.
This study uses advanced eye scans (OCT and retinal vessel imaging) to look for patterns in the retina that might be different in people with Multiple Sclerosis and other neuroinflammatory diseases. The goal is to find markers that could help doctors better understand and monitor these conditions.
This study looks at why some people with relapsing-remitting multiple sclerosis (RRMS) get worse even when they don't have relapses. It uses eye scans and other tests to find early signs of progression, which could help tailor treatments.
This trial uses a type of eye scan (OCT) to look at the retina in people with brain conditions like multiple sclerosis, Alzheimer's, Parkinson's, or migraines. It aims to see if these scans can help doctors learn more about the disease and monitor it over time.
Hear when a new Multiple sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.